Nandwani Monica Christine R
Johns Hopkins University School of Medicine, Division of Gastroenterology, Baltimore City, MD, USA.
Nurse Pract. 2010 Nov;35(11):32-9. doi: 10.1097/01.NPR.0000388900.49604.e1.
The FDA recently approved the use of the HPV quadrivalent vaccine, Gardasil, for the prevention of genital warts in males ages 9 through 26. This literature review seeks to examine men's knowledge of and interest in HPV vaccination as this could potentially affect vaccine uptake.
美国食品药品监督管理局（FDA）最近批准使用人乳头瘤病毒（HPV）四价疫苗加德西（Gardasil）来预防9至26岁男性的尖锐湿疣。这篇文献综述旨在研究男性对HPV疫苗接种的了解和兴趣，因为这可能会对疫苗的接种率产生潜在影响。
